Alison B. Fleming's most recent trade in Collegium Pharmaceutical Inc was a trade of 1,386 Common Stock done at an average price of $19.0 . Disclosure was reported to the exchange on Aug. 10, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Collegium Pharmaceutical Inc | Alison B. Fleming | EVP & Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.03 per share. | 10 Aug 2021 | 1,386 | 143,694 (0%) | 0% | 19.0 | 26,376 | Common Stock |
| Collegium Pharmaceutical Inc | Alison B. Fleming | EVP & Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.38 per share. | 01 Apr 2021 | 7,900 | 145,080 (0%) | 0% | 23.4 | 184,702 | Common Stock |
| Collegium Pharmaceutical Inc | Alison B. Fleming | EVP & Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.38 per share. | 01 Apr 2021 | 1,757 | 152,980 (0%) | 0% | 23.4 | 41,079 | Common Stock |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2021 | 5,984 | 154,737 (0%) | 0% | - | Common Stock | |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.95 per share. | 10 Feb 2021 | 5,045 | 156,164 (0%) | 0% | 26.0 | 130,918 | Common Stock |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.95 per share. | 10 Feb 2021 | 2,099 | 161,209 (0%) | 0% | 25.9 | 54,469 | Common Stock |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 45,360 | 156,779 (0%) | 0% | 0 | Common Stock | |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jan 2021 | 6,529 | 163,308 (0%) | 0% | - | Common Stock | |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Nov 2020 | 16,000 | 19,378 | - | - | Stock Option (Right to Purchase) | |
| Collegium Pharmaceutical Inc | Alison B. Fleming | Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.73 per share. | 18 Nov 2020 | 16,000 | 117,386 (0%) | 0% | 5.7 | 91,680 | Common Stock |